FBTCX vs. FSELX

In the year-to-date period, FBTCX achieves a -8.16% return, which is significantly lower than FSELX's -6.17% return. Over the past 10 years, FBTCX has underperformed FSELX with an annualized return of 2.57%, while FSELX has yielded a comparatively higher 23.89% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

FBTCX has a 1.75% expense ratio, which is higher than FSELX's 0.68% expense ratio.

This table presents a comparison of risk-adjusted performance metrics for Fidelity Advisor Biotechnology Fund Class C (FBTCX) and Fidelity Select Semiconductors Portfolio (FSELX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current FBTCX Sharpe Ratio is -0.28, which is lower than the FSELX Sharpe Ratio of -0.02. The chart below compares the historical Sharpe Ratios of FBTCX and FSELX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

FBTCX's dividend yield for the trailing twelve months is around 7.45%, less than FSELX's 9.20% yield.

The maximum FBTCX drawdown since its inception was -61.27%, smaller than the maximum FSELX drawdown of -81.70%. Use the drawdown chart below to compare losses from any high point for FBTCX and FSELX.

Fidelity Advisor Biotechnology Fund Class C (FBTCX) and Fidelity Select Semiconductors Portfolio (FSELX) have volatilities of 9.88% and 9.58%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.